Summit Pharmaceuticals Europe closed  in February  2018 a partnership with the Czech company InStar Technologies for the promotion of their innovative and proprietary drug delivery carrier InStrip™ based on a nanotechnology. InStar’s  goal is to bring new transmucosal administration of drugs that are still available only by injections.

InStrip™ technology provides all the benefits associated with submucosal drug delivery and with a broader range of drug candidates like peptides, proteins, hormones, enzymes or vaccines, stabilization of such kind of substances in room temperature, protection of API against saliva, increase solubility and bioavailability, lead the pharmacokinetics from fast to sustained etc. 

In case of interest in InStrip™ technology please contact: